Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 0.74 |
| ▸ | GAA | P10253 | 2/20 | 0.74 |
| ▸ | PKM | P14618 | 2/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.63 |
| ▸ | CA3 | P07451 | 1/20 | 0.63 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.63 |
| ▸ | CA4 | P22748 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sinapic Acid Methyl Ether SCHEMBL207442 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL9848210 | 0.98 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL30365738 | 0.98 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL9757598 | 0.98 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL9757606 | 0.98 | KDM4E (0.96) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL29012255 | 0.92 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL29012285 | 0.92 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL11832578 | 0.92 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL29012253 | 0.92 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| Sinapic Acid Methyl Ether SCHEMBL11832571 | 0.92 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144770-A1 | COMPOSITION FOR INHIBITING SEBUM SECRETION CONTAINING A THYMOL ESTER-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2026-05-28 | — | — | US | claimed |
| WO-2026099270-A1 | BIODEGRADABLE UV ABSORBERS AND USES THEREOF II | BASF SE (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2025242899-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242885-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242884-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | claimed |
| US-20250213448-A1 | COMPOSITION FOR PROTECTING SKIN CONTAINING A THYMOL ESTER-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2025-07-03 | — | — | US | claimed |
| US-20250177269-A1 | COMPOSITION FOR PROMOTING HAIR SPROUTING OR HAIR GROWTH CONTAINING A THYMOL ESTER-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2025-06-05 | — | — | US | claimed |
| US-20250163379-A1 | METHOD FOR DIFFERENTIATING HEMATOPOIETIC STEM/PROGENITOR CELLS INTO NK CELLS | HEMACELL BIOTECHNOLOGY INC. (CN) | 2025-05-22 | — | — | US | claimed |
| US-20250127696-A1 | COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2025-04-24 | — | — | US | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0174064-B1 | COMPOSITIONS AND COMPOUNDS FOR THE TREATMENT OF PROSTATIC ADENOMA | INVERNI DELLA BEFFA S.P.A. (IT) | 1989-12-06 | — | — | EP | claimed |
| US-4709076-A | UROGENITAL DISORDERS | INVERNI DELLA BEFFA SPA (IT) | 1987-11-24 | — | — | US | claimed |
| EP-0174064-A2 | Compositions and compounds for the treatment of prostatic adenoma | INVERNI DELLA BEFFA S.P.A. (IT) | 1986-03-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144770-A1 | COMPOSITION FOR INHIBITING SEBUM SECRETION CONTAINING A THYMOL ESTER-BASED COMPOUND | TSLP, AQP4, AQP3 | KDM4E 2099/4885ALDH1A1 3166/4885HPGD 1667/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | KDM4E 1814/4885ALDH1A1 1569/4885HPGD 3145/4885 |
| US-20250213448-A1 | COMPOSITION FOR PROTECTING SKIN CONTAINING A THYMOL ESTER-BASED COMPOUND | ERCC2, OGG1, UNG | KDM4E 3255/4885ALDH1A1 1191/4885HPGD 822/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | KDM4E 1567/4885ALDH1A1 1723/4885HPGD 1878/4885 |
| US-20250177269-A1 | COMPOSITION FOR PROMOTING HAIR SPROUTING OR HAIR GROWTH CONTAINING A THYMOL ESTER-BASED COMPOUND | TTL, NGF, MST1 | KDM4E 2273/4885ALDH1A1 1394/4885HPGD 1101/4885 |
| US-20250127696-A1 | COMPOSITION FOR PREVENTING OR IMPROVING SKIN-AGING CONTAINING A THYMOL ESTER-BASED COMPOUND | GLA, GLB1, TYR | KDM4E 3505/4885ALDH1A1 1135/4885HPGD 865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.